Press Release

Monday, 06 November 2017

Innovation is the basis for new fibrosis treatment

It is often the case that one only realizes how important something is when it stops working. Researchers at Hannover Medical School (MHH) have capitalized on this fact: using a new method, they succeeded in specifically deactivating some 4,000 ribonucleic acids (RNAs) in cells to elucidate their function. For example, they were able to show that a particular RNA is required for the growth of connective-tissue cells (fibroblasts). “The technique we’ve developed can now be employed in various studies and thus help to explain the origin of numerous diseases – and, building on this, to find new treatments,” says Professor Thomas Thum, director of MHH’s Institute of Translational and Molecular Therapeutic Strategies (IMTTS). The prestigious journal Cell Death & Differentiation has published the findings of this scientific investigation.

Download the press release (in German):
171106_Thum_Beermann_Baer.pdf